Second annual assembly, sponsored by the Department of Biology and Picower Institute, invited postdocs from across the country to meet with faculty, present their work to the MIT community, and build relationships.
The Building 68 manager’s leadership, innovation, and laid-back attitude have helped to build a strong culture of community.
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
Ranking at the top for the 13th year in a row, the Institute also places first in 11 subject areas.
The fellowships provide five years of funding to doctoral students in applied science, engineering, and mathematics who have “the extraordinary creativity and principled leadership necessary to tackle problems others can’t solve.”
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
The Fulbright US Student Program funds research, study, and teaching opportunities abroad.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
The Institute also ranks second in five subject areas.
Professors Adam Martin and Joel Volman explain the genesis, scope, and objectives of the recently launched Task Force on the MIT Undergraduate Academic Program.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
Software allows scientists to model shapeshifting proteins in native cellular environments.